ARKG Investment Tracker

Source from:official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·11-18 07:13
      ARKG Investment Tracker position change: Increased position in Illumina by 2,335 shares, the number of shares held increased 0.56% compared to the previous period and now represents 4.54% of the total position.
      27Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-18 07:13
      ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 13,525 shares, the number of shares held increased 0.56% compared to the previous period and now represents 3.75% of the total position.
      36Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-18 07:13
      ARKG Investment Tracker position change: Cleared position in Iambic Therapeutics by 1,736,486 shares, the number of shares held decreased 100% compared to the previous period and now represents 0% of the total position.
      15Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-18 07:13
      ARKG Investment Tracker position change: Increased position in Kymera Therapeutics, Inc. by 705 shares, the number of shares held increased 0.56% compared to the previous period and now represents 0.85% of the total position.
      14Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-18 07:13
      ARKG Investment Tracker position change: Increased position in Tempus AI by 7,424 shares, the number of shares held increased 0.27% compared to the previous period and now represents 10.34% of the total position.
      65Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-18 07:13
      ARKG Investment Tracker position change: Increased position in Generate Biomedicines by 9,465 shares, the number of shares held increased 0.56% compared to the previous period and now represents 1.07% of the total position.
      9Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-18 07:13
      ARKG Investment Tracker position change: Increased position in Ionis Pharmaceuticals by 5,250 shares, the number of shares held increased 0.56% compared to the previous period and now represents 1.43% of the total position.
      9Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-18 07:13
      ARKG Investment Tracker position change: Increased position in Beam Therapeutics, Inc. by 17,940 shares, the number of shares held increased 0.56% compared to the previous period and now represents 3.85% of the total position.
      7Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-18 07:13
      ARKG Investment Tracker position change: Increased position in Freenome, Inc. by 10,305 shares, the number of shares held increased 0.56% compared to the previous period and now represents 1.01% of the total position.
      7Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-18 07:13
      ARKG Investment Tracker position change: Increased position in Alamar Biosciences by 6,725 shares, the number of shares held increased 0.56% compared to the previous period and now represents 1.95% of the total position.
      72Comment
      Report
     
     
     
     

    Most Discussed